| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_18d7a3351b44de1ec794cb4acd1e6221
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_20de9997de8dc4eee6d9906aa8b31cc1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5d1aabbc42d1303e62a6bb1508070e9b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9f503b76d4dfdb863d618e70e8e54803
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c8ef82540a9c9763fdb736bdacb39b9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_06b2c0e51935176accafbd90a8651cb3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-804
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-884 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001154
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-20 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| filingDate |
2019-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0907e1e8b36c23ce443780d3a171725f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9998c43d1e075656bb752a7c71515f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bfdc369938acefdee03196bfed33f6de
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c65d45084bd53ae1704c7250d1e021a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99acea4435e190353e4af0e56b93118b |
| publicationDate |
2020-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2020081996-A1 |
| titleOfInvention |
Compositions and methods for manufacturing bacteriophage cancer vaccines and uses thereof |
| abstract |
Disclosed herein are methods and compositions for manufacturing nanoparticle bacteriophage-based vaccines that are useful for anti-cancer treatments. Also disclosed herein are methods of using bacteriophage-based vaccines expressing aspartyl (asparaginyl) β-hydroxylase for treating cancer. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020223639-A1 |
| priorityDate |
2018-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |